BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33014187
Number of visits today
5507
Number of downloads
16204979
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Pastwińska J, Karaś K, Karwaciak I, Ratajewski M. Targeting EGFR in melanoma - The sea of possibilities to overcome drug resistance. Biochim Biophys Acta Rev Cancer 2022;1877:188754. [PMID: 35772580 DOI: 10.1016/j.bbcan.2022.188754] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Noguchi S, Yasumura M. The potential therapeutic efficiency of pan-ERBB inhibitors for canine glioma.. [DOI: 10.21203/rs.3.rs-2452372/v1] [Reference Citation Analysis]
2 Ji F, Qiu X. Non-Apoptotic Programmed Cell Death in Thyroid Diseases. Pharmaceuticals (Basel) 2022;15. [PMID: 36559016 DOI: 10.3390/ph15121565] [Reference Citation Analysis]
3 Mahdavi Gorabi A, Sadat Ravari M, Sanaei M, Davaran S, Kesharwani P, Sahebkar A. Immune checkpoint blockade in melanoma: Advantages, shortcomings and emerging roles of the nanoparticles. International Immunopharmacology 2022;113:109300. [DOI: 10.1016/j.intimp.2022.109300] [Reference Citation Analysis]
4 Slastnikova TA, Rosenkranz AA, Ulasov AV, Khramtsov YV, Lupanova TN, Georgiev GP, Sobolev AS. Mouse Syngeneic Melanoma Model with Human Epidermal Growth Factor Receptor Expression. Pharmaceutics 2022;14. [PMID: 36432639 DOI: 10.3390/pharmaceutics14112448] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345